Online citations, reference lists, and bibliographies.
← Back to Search

ENVIRONMENTAL AND OCCUPATIONAL RISK FACTORS AND PREDICTORS OF SURVIVAL AMONG MALIGNANT PLEURAL MESOTHELIOMA PATIENTS

A. Abdel-HamidM, E. AmmarN, A. Shoman, M. Elhoussinie, H. Elwakeel
Published 2019 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
AbstractIntroduction: Malignant pleural mesothelioma (MPM) remains a serious health problem due to the poor outcome of different therapies. In Egypt, it is mainly attributed to an environmental origin with a high incidence in women and young adults. Aim of work: To identify risk factors of malignant pleural mesothelioma and to carry out survival analysis for malignant pleural mesothelioma patients attending outpatient clinic of Clinical Oncology department at Ain Shams University hospital. Materials and methods: Ninety cases with pathologically confirmed MPM attending the outpatient clinic of clinical oncology department at Ain Shams University hospital were interviewed. Patients in critical conditions who needed hospitalization or palliative treatment were excluded. Included patients were then followed up for two years starting from the date of diagnosis. Results: Logistic regression analysis revealed that living in industrial areas, household exposure to asbestos and history of smoking were significant risk factors of MPM. The mean survival duration of all cases was 24.49 months. Cox regression analysis revealed that factors predicting survival were age and gender. The difference in survival between patients treated with different treatment modalities was not statistically significant. Conclusion: Environmental and householdexposure to asbestos as well as smoking play an important role in occurrence of MPM. Age and gender were significant predictors of survival of patients. Strict measures to reduce pollution and thus rates of MPM should be adopted in addition to communityawareness of the possible risk factors and preventive measures. Moreover, development of a national record system is required to determine the true size and scope of this environmental problem in Egypt.
This paper references
10.1002/ajim.20780
Case-control study of pleural mesothelioma in workers with social security in Mexico.
G. Aguilar-Madrid (2010)
Malignant and NonMalignant Asbestos-Related Pleural and Lung Disease : 10-Year Follow-Up Study
Slavica Cvitanoviæ (2003)
10.1038/bjc.2014.478
Factors associated with survival in a large series of patients with malignant pleural mesothelioma in New South Wales
A. Linton (2014)
Epidemiology of Mesothelioma in the Clinical Oncology Department of Ain Shams University Hospitals in Cairo
W Anwar (2014)
Asbestos and mesothelioma in Egypt
RM Gaafar (2007)
10.4997/JRCPE.2015.207
Survival from malignant mesothelioma: where are we now?
A. Marshall (2015)
10.3978/j.issn.2225-319X.2012.11.04
Malignant pleural mesothelioma: an epidemiological perspective.
Benjamin M. Robinson (2012)
Mesothelioma in Egypt
N Eldin (2005)
10.1111/j.1759-7714.2010.00033.x
Malignant pleural mesothelioma: A retrospective analysis of clinicopathological and survival data
Azza M. Adel (2011)
10.17925/OHR.2008.04.1.60
Malignant Pleural Mesothelioma—A Current Review
M. Ballas (2008)
10.1128/mBio.00904-14
Use and Misuse of Statistical Significance in Survival Analyses
Yoichi Furuya (2014)
10.5114/aoms.2010.19303
Epidemiology of mesothelioma in Egypt. A ten-year (1998-2007) multicentre study
Yosri M. Akl (2010)
10.1016/J.LUNGCAN.2007.02.004
Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results.
F. Rea (2007)
10.1136/oemed-2016-104119
The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure
A. Marinaccio (2018)
10.1055/s-0032-1326061
[Epidemiological and occupational medicine aspects of pleural mesothelioma].
B. Karabin-Kehl (2013)
A retrospective study of chemotherapy with and without pemetrexed in malignant pleural mesothelioma.
M. Higashiguchi (2012)
10.1186/1750-1172-3-34
Malignant mesothelioma
A. Moore (2008)
10.5094/APR.2011.051
Airborne asbestos fibres and mesothelioma in the last 20 years in Egypt: a review
A. Awad (2011)
[Malignant mesothelioma risk factors: experience in the General Hospital of Mexico].
A. Hernández-Solís (2013)
10.1016/j.ejcts.2010.12.024
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
D. Sugarbaker (2011)
10.1186/2052-4374-25-10
Systematic Review of the Effects of Asbestos Exposure on the Risk of Cancer between Children and Adults
D. Kang (2013)
10.1371/journal.pone.0145039
Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients
E. Taioli (2015)
10.1200/JCO.2013.31.15_SUPPL.E18544
Clinical characteristics, treatment and survival outcomes in malignant pleural mesothelioma: an institutional experience in Turkey.
M. Kuçukoner (2014)
10.1017/erm.2012.6
Molecular pathogenesis of malignant mesothelioma.
P. Rascoe (2012)
10.1186/1471-2458-12-314
Mesothelioma incidence surveillance systems and claims for workers’ compensation. Epidemiological evidence and prospects for an integrated framework
A. Marinaccio (2012)
Pleural mesothelioma: diagnostic problems and evaluation of prognostic factors.
H. Ismail (2006)
10.2307/2531021
Sample-size formula for the proportional-hazards regression model.
D. Schoenfeld (1983)
Malignant Pleural Mesothelioma—A Current Review. US Oncological Review; 4(1):60-3
MS Balla (2008)
10.1002/ijc.23874
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
10.1155/2014/437971
Cancer Incidence in Egypt: Results of the National Population-Based Cancer Registry Program
A. S. Ibrahim (2014)
10.5761/ATCS.OA.09.01427
Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients.
R. Bagheri (2011)
10.4081/MONALDI.2006.551
Non-occupational malignant pleural mesothelioma due to asbestos and non-asbestos fibres.
L. Proietti (2006)
10.21037/atm.2017.06.26
Malignant pleural mesothelioma: predictors and staging.
W. Richards (2017)



Semantic Scholar Logo Some data provided by SemanticScholar